0001628280-22-018113.txt : 20220627
0001628280-22-018113.hdr.sgml : 20220627
20220627205429
ACCESSION NUMBER: 0001628280-22-018113
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220623
FILED AS OF DATE: 20220627
DATE AS OF CHANGE: 20220627
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tessier-Lavigne Marc
CENTRAL INDEX KEY: 0001437435
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38311
FILM NUMBER: 221046288
MAIL ADDRESS:
STREET 1: 1 DNA WAY
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Denali Therapeutics Inc.
CENTRAL INDEX KEY: 0001714899
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 463872213
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 161 OYSTER POINT BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 866-8548
MAIL ADDRESS:
STREET 1: 161 OYSTER POINT BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
wf-form4_165637764875845.xml
FORM 4
X0306
4
2022-06-23
0
0001714899
Denali Therapeutics Inc.
DNLI
0001437435
Tessier-Lavigne Marc
C/O DENALI THERAPEUTICS INC.
161 OYSTER POINT BLVD.
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
Common Stock
2022-06-23
4
D
0
13250
31.1001
D
2017106
D
Common Stock
2022-06-24
4
D
0
39984
30.5299
D
1977122
D
Common Stock
2022-06-24
4
D
0
6766
31.0761
D
1970356
D
Common Stock
78848
I
The Tessier-Lavigne/Hynes Irrevocable Trust 1
Common Stock
79173
I
The Tessier-Lavigne/Hynes Irrevocable Trust 2
Common Stock
78848
I
The Tessier-Lavigne/Hynes Irrevocable Trust 3
The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $30.00 to $30.19 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
Includes 5,986 unvested restricted stock units.
The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $30.00 to $30.99 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $31.00 to $31.19 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
/s/ Tyler Nielsen, by power of attorney
2022-06-27